dantetzl – Hibiscus BioVentures

All

Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research

All

connectRN raises $76M for healthcare worker staffing, networking

All

Cellevolve Launches with Acclaimed Investors and Pivotal Manufacturing Partnership, Focused on Accelerating the Commercialization of Novel Cell Therapies

All NexImmune

NexImmune Announces Pricing of Upsized Initial Public Offering

All NexImmune

Immunotherapy Veteran Robert Knight, MD, Joins NexImmune as Chief Medical Office

All

Bayer and Northpond Ventures Lead USD 55 million Series A Financing Round for Triumvira Immunologics

All NexImmune

NexImmune to Present at the Jefferies Virtual Healthcare Conference

All Cereno Scientific

The Board and Chief Executive Officer of Cereno Scientific AB here with present the Interim Report for the first quarter 2020

All Cereno Scientific

Cereno Scientific announces US subsidiary in Cambridge, Boston, MA

All Cereno Scientific

Cereno Scientific adds a clinical expert to its ODD track

© 2022 Hibiscus BioVentures.